O-4-O-((2,3-DIHYDROXYPROPOXY)HYDROXYPHOSPHINYL)-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-.ALPHA.-D-GALACTOPYRANOSYL-(1->3)-O-.BETA.-D-GALACTOPYRANOSYL-(1->4)-.BETA.-D-GLUCOPYRANOSE
UNII YH7JKA8CJ2
Substance Identification & Data
This profile provides standardized clinical and technical data for O-4-o-((2,3-dihydroxypropoxy)hydroxyphosphinyl)-.alpha.-d-glucopyranosyl-(1->4)-o-.alpha.-d-galactopyranosyl-(1->3)-o-.beta.-d-galactopyranosyl-(1->4)-.beta.-d-glucopyranose, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YH7JKA8CJ2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1160241-07-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H49O26P AOXNQGPDZJZYKL-HCQCMHBCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for O-4-o-((2,3-dihydroxypropoxy)hydroxyphosphinyl)-.alpha.-d-glucopyranosyl-(1->4)-o-.alpha.-d-galactopyranosyl-(1->3)-o-.beta.-d-galactopyranosyl-(1->4)-.beta.-d-glucopyranose. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.